mild COVID-19 – Page 2 – Communicable Diseases Research

Recruitment of highly cytotoxic CD8 + T cell receptors in mild SARS-CoV-2 infection

경증 SARS-CoV-2 감염에서 세포독성이 높은 CD8 + T 세포 수용체 모집

Article

Published on 2022-01-112022-09-11
Journal: Cell Reports [Category] SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed Antigen CD8 CD8(+) T cells Combination convalescent individuals coronavirus Cytotoxic T cells cytotoxicity demonstrated epitope Epitopes feature functional gene signature gene signatures heterogeneous HLA human leukocyte antigen Immunity immunodominant infected cells Infection investigated leukocyte Mild mild COVID-19 mild SARS-CoV-2 infection polyclonal Protective protective immunity Quantitative recruited respiratory responses retrieved SARS-CoV-2 SARS-CoV-2 epitope SARS-COV-2 infection scRNA sequencing. Sequencing severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 T cell T cell immunity T cell receptor T cells TCR TCR engineering TCR identification TCRs virus-infected cells
[DOI] 10.1016/j.celrep.2021.110214 PMC 바로가기 [Article Type] Article

Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19

가벼운 코비드 19를 가진 회수 된 어린이의 임상 및 면역 반응 평가

Article

Published on 2022-01-042022-09-01
Journal: Viruses [Category] 변종, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome addition age Antibody Response Asymptomatic caused Cell Cellular immune response children clinical Clinical data collected consequence coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 cases detectable discharged Health highlight IFN-γ IgG IgM immune memory immune responses Infant Infants Infection Inflammation less lung imaging abnormalities lung imaging abnormality lung lesion lung lesions memory memory B memory B cell memory T cell memory T cells mild COVID-19 Neutralizing antibodies neutralizing antibody no significant difference nucleocapsid protein recovered recovered children respiratory response returned robust SARS-CoV-2 secretion severe acute respiratory syndrome Coronavirus Spread symptom onset symptomatic T cells variant variants whole blood sample
[DOI] 10.3390/v14010085 PMC 바로가기 [Article Type] Article

Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group

중증 및 경증 COVID-19 환자 및 대조군의 혈청 총 IgA 수치 비교

Article

Published on 2022-01-012022-09-12
Journal: Journal of Clinical Immunology [Category] MERS, 진단,

[키워드] ANOVA test antibody Asymptomatic calculated changes in collected Combination Control control group COVID-19 cross-sectional death group healthy subject IgA IgA level IgG IgG level immune system Immunity independent Infection investigated Iran laboratory data Level Mild mild COVID-19 mild COVID-19 patient mucosal nasal no symptom p value performed positive reduce secretion serology serum Serum IgA level serum IgG severe COVID-19 severe COVID-19 patient severity severity of COVID-19 shown significant negative correlation significantly SPSS software Statistical tests statistically significant study group subject three group Total vaccination Vaccine virus transmission
[DOI] 10.1007/s10875-021-01149-6 PMC 바로가기 [Article Type] Article

A randomized, open-label, multicentre, comparative study of therapeutic efficacy, safety, and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb, in the treatment of mild forms of COVID-19

Original Contribution

Published on 2021-08-282022-10-31
Journal: Clinical Phytoscience [Category] COVID-19,

[키워드] 1:1 acetaminophen addition Adverse drug reaction analysed Anosmia antipyretics average baseline benefit BNO 1030 both group clinical trial clinically comparable control group coughing COVID 19 COVID-19 COVID19 decrease defined diagnosed discharge effective Efficacy evaluation criteria Fever Final form greater decrease groups Hospitalization hospitalized patient ibuprofen Imupret® increase in Laboratory Mild mild case mild COVID-19 mild COVID-19 symptom moderate Most patient multicentre myalgia nasal nasal congestion NSAIDS offer open label Open-label Outpatient Patient phytotherapy positive patient primary endpoint randomised Randomized recovered patient reduction Registered reported respiratory infection Result Safe screened severity of symptom Significant sore throat Symptom symptomatic Symptomatic treatment the patient therapeutic efficacy therapy Tolerability treated Treatment Trial Visual Analogue Scale were assessed
[DOI] 10.1186/s40816-021-00308-x PMC 바로가기 [Article Type] Original Contribution

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Article

Published on 2021-02-012023-07-06
Journal: Clinical microbiology and infection : the official [Category] SARS,

[키워드] description Follow-up mild COVID-19 Moderate COVID-19 Noncritical COVID-19 outcomes persisting symptoms
[DOI] 10.1016/j.cmi.2020.09.052 PMC 바로가기

Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study

Article

Published on 2020-08-102023-06-16
Journal: Pharmacological research [Category] MERS,

[키워드] Hanshiyi Formula mild COVID-19 Moderate COVID-19 The proportion to severe status Traditional Chinese medicine
[DOI] 10.1016/j.phrs.2020.105127 PMC 바로가기 [Article Type] Article

Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies

Immunology

Published on 2020-08-072022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] antibody production Case report Concentration COVID-19 COVID-19 patient COVID-19 patients diagnosed discharge discharged Duration fluorescent Health Hospitalized IgG IgG antibody IgM IgM and IgG IgM antibodies IgM antibody immunochromatography male Mild mild COVID-19 mild symptoms much lower occur persistent infection physical positive Prevent Production quarantine reached recurrence reported SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 RNA detection Severe case Specific specimen Stool Surveillance the antibody the patient undetectable virus virus spread virus-specific antibody response Virus-specific IgG was used Wuhan
[DOI] 10.3389/fimmu.2020.01936 PMC 바로가기 [Article Type] Immunology